Search for: "Doe v. Board of Registration in Medicine" Results 41 - 60 of 68
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jun 2012, 8:38 pm by Charon QC
“When freedom does not have a purpose, when it does not wish to know anything about the rule of law engraved in the hearts of men and women, when it does not listen to the voice of conscience, it turns against humanity and society. [read post]
1 Oct 2011, 12:51 am by Apeng
(Patent Docs) (Patently-O) (IP Spotlight) (Patent Baristas) US: CAFC: Patent exhaustion does not apply to genetically engineered seed: Monsanto Co. v. [read post]
5 Jul 2011, 4:28 am
Do you make, sell, buy, or use medicines? [read post]
8 Feb 2010, 4:02 am
(Class 99) District Court Delaware: Grant of preliminary injunction does not establish objective recklessness for wilfulness: Cordis Corporation v. [read post]
28 Jan 2010, 4:51 am by Jonathan Rosenfeld
Prescription drugs are invaluable tools in the practice of medicine, used to treat numerous illnesses and diseases. [read post]
14 Apr 2009, 8:06 am
  Career dissatisfaction is not exclusive to law; much is heard about unhappiness in medicine, accounting, teaching, and other professions. [read post]
20 Dec 2008, 3:00 am
(IP Dragon) Columbia Sportswear successful in reducing counterfeits in China (IP Dragon) Shenyang Intermediate People’s Court orders New Apple Concept Technology to pay Apple 400,000 Yuan in damages for trade mark infringement and unfair competition (DeBund) 2386 IPR cases dealt with by Culture Administrations in Q3 (DeBund) Well-known trade marks can be recognised on basis of the products’ sales volumes (DeBund) Judicial Criteria for copyright cases (part 2) (DeBund) Beer and… [read post]
21 Nov 2008, 1:36 pm
Court of First Instance rejects Lego’s appeal against OHIM’s Board of Appeals decision that Lego brick shape not registrable as a Community trade mark (Ars Technica) (Techdirt) OHIM opposition quality standards – the Office responds (IPKat) Charlie McCreevy puts forward proposal to reduce CTM fees by about 40% (Managing Intellectual Property) (Class 46) New protected geographical indications: French PGI Boeuf de Bazas for fresh meat and offal; Finnish… [read post]
5 Sep 2008, 11:01 pm
& Ors v Deisel Spa and Case C-302/08 Zino Davidoff SA v Bendesfinanzdirektion Sudost: (Class 46), EPO Boards of Appeal finds that when a fax is transmitted and an ‘OK’ is noted by the sender, this is evidence that the transmission was successful: (IPKat), Professor Hugenholtz slams European Commission for ignoring evidence on copyright extension: (Techdirt)   Germany Federal Patent Court publishes guidelines on colour trade mark Signal… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences:… [read post]
20 Jun 2008, 8:07 am
– Marks & Clerk Biotechnology Report 2008: (IP finance), Pfizer and Daiichi-Sankyo’s bidding for Ranbaxy: (IP ThinkTank), (IAM), (Managing Intellectual Property), (GenericsWeb), Cutting Edge Information study reveals 53% of pharma patents approach expiration before litigation strategies are implemented: (Peter Zura's 271 Patent Blog), Quanta and agricultural biotechnology: (Holman’s Biotech IP Blog), Breakthough by WHO will give poor countries better access… [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation amendments to dodge real story:… [read post]
30 May 2008, 9:09 am
: (Spicy IP), India: DCGI preparing document to implement patent-registration linkage: (Spicy IP), New Zealand: Generic pharmaceutical companies taking advantage of NZ IP laws and medicines regulations: (International Law Office), Uganda: Cipla licenses ARV technology into Uganda: (Afro-IP), US: Money saved through generic prescriptions: (GenericsWeb), US: Government plans to keep close tab on drug patent settlements: (GenericsWeb), US: FTC reports 14 deals to delay generics in… [read post]
23 May 2008, 1:03 am
: (Technological Innovation and Intellectual Property), Does Petra Moser show patents encourage successful innovation? [read post]